Your browser doesn't support javascript.
loading
Disease-modifying therapies for relapsing/active secondary progressive multiple sclerosis - a review of population-specific evidence from randomized clinical trials.
Bayas, Antonios; Christ, Monika; Faissner, Simon; Klehmet, Juliane; Pul, Refik; Skripuletz, Thomas; Meuth, Sven G.
Affiliation
  • Bayas A; Department of Neurology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
  • Christ M; Department of Neurology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
  • Faissner S; Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Klehmet J; Department of Neurology, Jüdisches Krankenhaus Berlin, Berlin, Germany.
  • Pul R; Department of Neurology and Center for Translational and Behavioral Neurosciences (C-TNBS), University Medicine Essen, Essen, Germany.
  • Skripuletz T; Department of Neurology, Hannover Medical School, Hannover, Germany.
  • Meuth SG; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Moorenstr. 5, Düsseldorf 40225, Nordrhein-Westfalen, Germany.
Ther Adv Neurol Disord ; 16: 17562864221146836, 2023.
Article in En | MEDLINE | ID: mdl-36710720
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Screening_studies Language: En Journal: Ther Adv Neurol Disord Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Screening_studies Language: En Journal: Ther Adv Neurol Disord Year: 2023 Document type: Article Affiliation country: Country of publication: